NEW: Ginkgo Bioworks Bioworks began making layoffs this week. Here's what we know so far: bizjournals.com/boston/news/20…

The 911 system is down across Massachusetts. In Boston, here's how to call for an emergency. Boston Fire: 617-343-2880. Boston EMS: 617-343-1400 Boston police: Use one of the nearby red boxes and/or call your district station directly (numbers below) 👇🏽 #mapoli #bospoli

Boston Scientific Corp.’s latest acquisition will add medical devices to prevent strokes to its portfolio. bizjournals.com/boston/news/20…

The FDA has expanded its previous approval for Sarepta Therapeutics’ gene therapy to treat Duchenne muscular dystrophy — but the regulatory agency didn't go quite as far in its approval as the company had hoped. $SRPT bizjournals.com/boston/news/20…

After starting companywide layoffs last week, Ginkgo Bioworks Holdings Inc. has now disclosed the wide-ranging impact of the job cuts, which number into the hundreds. $DNA bizjournals.com/boston/news/20…

After beginning companywide layoffs last week, Ginkgo Bioworks Bioworks Inc. has disclosed the scope of its ongoing job cuts, which number into the hundreds. bizjournals.com/boston/news/20…

We completed layoffs yesterday at Ginkgo and had to let go of many truly excellent Bioworkers. This was the hardest change we've made at Ginkgo Bioworks and it's on myself and leadership for the decisions that led up to it. People come to Ginkgo because they want to develop new

More layoffs are coming at the state's largest biotech employer just a few weeks after the pharmaceutical giant announced it planned to lay off 641 Massachusetts employees. bizjournals.com/boston/news/20…

More job cuts are coming at Takeda just a few weeks after the pharmaceutical giant announced it planned to lay off 641 Massachusetts employees. bizjournals.com/boston/news/20…

I spoke with Josh Brumm, former CEO of Dyne Therapeutics, about his new role at Forbion and the firm's decision to open its first U.S. office in Boston. bizjournals.com/boston/news/20…

To build its new 300-bed inpatient cancer care hospital, Dana-Farber Cancer Institute revealed in a filing Thursday that it plans to demolish the Joslin Diabetes Center building in the Longwood Medical Area. bizjournals.com/boston/news/20…

Anheuser-Busch to cut 193 jobs in Massachusetts. Hannah Green bizjournals.com/boston/news/20…

Thank you Hannah Green of Boston Business Journal for profiling the MassBio @BiotechTVHQ Kendall Square podcast studio! bizjournals.com/boston/news/20…

Biogen Inc. is now projecting better full-year financial results that it was a few months ago as the company continues to see an uptick in sales from Leqembi, the Alzheimer's disease drug it developed in partnership with Eisai Inc. bizjournals.com/boston/news/20…

The Massachusetts Life Sciences Center will no longer offer its angel investor tax credit, a program designed to drive early-stage investment in life science startups. Economic Development Secretary Yvonne Hao told the Boston Business Journal why it was cut. bizjournals.com/boston/news/20…

BREAKING: Sage Therapeutics is rejecting the unsolicited acquisition offer from Biogen — but, it's open to other deals. bizjournals.com/boston/news/20…

Scoop: Lyndra Therapeutics, a drug developer that spun out of the lab of MIT professor Bob Langer in 2015, is winding down operations after running out cash. bizjournals.com/boston/news/20…

Heather Hay’s two sons have Duchenne muscular dystrophy. Elevidys' approval opened the door for her younger son to be treated with the gene therapy in 2023. Hay’s elder son was set to receive Elevidys in August. Now, his treatment is indefinitely on hold. bizjournals.com/boston/news/20…